IndraLab

Statements

MiR-4429 inhibits YOD1. 1 / 1

| 1

➶

reach

"It has been reported that miR-4429 inhibits the malignant development of ovarian cancer by targeting YOD1."

35642058

INDRA sources:

Colored badges next to statement headings correspond to evidence counts from knowledge sources, as shown below. Badges to the left of the | separator correspond to curated knowledge base sources, and badges to the right of it correspond to machine reading systems.

IndraLab

Statements

MiR-4429 inhibits YOD1. 1 / 1

INDRA sources:

Databases

Reading